Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Heart Retrieve available abstracts of 143 articles: HTML format Text format

Single Articles

July 2018
1. KUMAR N
   Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
   Heart. 2018;104:1135.
   PubMed     Text format    
   
   
   May 2018
2. DOCHERTY KF, Jhund PS
   Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?
   Heart. 2018 May 14. pii: heartjnl-2018-313371. doi: 10.1136/heartjnl-2018-313371
   PubMed     Text format    
   
   
   
3. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
   Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
   Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
   PubMed     Text format     Abstract available
   
   
   April 2018
4. BEYGUI F, Van Belle E, Ecollan P, Machecourt J, et al
   Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
   Heart. 2018 Apr 25. pii: heartjnl-2018-312950. doi: 10.1136/heartjnl-2018-312950
   PubMed     Text format     Abstract available
   
   
   
5. NIJJER SS
   Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
   Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967
   PubMed     Text format    
   
   
   
6. MUNDAL LJ, Igland J, Veierod MB, Holven KB, et al
   Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.
   Heart. 2018 Apr 5. pii: heartjnl-2017-312706. doi: 10.1136/heartjnl-2017-312706.
   PubMed     Text format     Abstract available
   
   
   
7. OTTO CM
   Heartbeat: Acute myocardial infarction: one test to diagnose them all?
   Heart. 2018;104:625-627.
   PubMed     Text format    
   
   
   March 2018
8. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
   Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
   Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
   PubMed     Text format     Abstract available
   
   
   
9. JOHNSTONE SR, Isakson BE
   'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
   Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084
   PubMed     Text format    
   
   
   
10. SEPEHRVAND N, James SK, Stub D, Khoshnood A, et al
    Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials.
    Heart. 2018 Mar 29. pii: heartjnl-2018-313089. doi: 10.1136/heartjnl-2018-313089
    PubMed     Text format     Abstract available
    
    
    
11. HAKULINEN C, Pulkki-Raback L, Virtanen M, Jokela M, et al
    Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women.
    Heart. 2018 Mar 27. pii: heartjnl-2017-312663. doi: 10.1136/heartjnl-2017-312663
    PubMed     Text format     Abstract available
    
    
    
12. EDFORS R, Sahlen A, Szummer K, Renlund H, et al
    Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312436. doi: 10.1136/heartjnl-2017-312436
    PubMed     Text format     Abstract available
    
    
    
13. GRIMALDI-BENSOUDA L, Danchin N, Dallongeville J, Falissard B, et al
    Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.
    Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534
    PubMed     Text format     Abstract available
    
    
    February 2018
14. LAMPREA-MONTEALEGRE JA, McClelland RL, Grams M, Ouyang P, et al
    Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312794. doi: 10.1136/heartjnl-2017-312794
    PubMed     Text format     Abstract available
    
    
    
15. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    PubMed     Text format     Abstract available
    
    
    
16. GARD A, Lindahl B, Batra G, Hadziosmanovic N, et al
    Interphysician agreement on subclassification of myocardial infarction.
    Heart. 2018 Feb 16. pii: heartjnl-2017-312409. doi: 10.1136/heartjnl-2017-312409
    PubMed     Text format     Abstract available
    
    
    
17. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.
    PubMed     Text format    
    
    
    
18. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    PubMed     Text format     Abstract available
    
    
    January 2018
19. SINGH D, Bhat R, Kothari SS
    25-year-old man with chest pain.
    Heart. 2018;104:72.
    PubMed     Text format     Abstract available
    
    
    
20. MURPHY A, Johnson CO, Roth GA, Forouzanfar MH, et al
    Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.
    Heart. 2018;104:58-66.
    PubMed     Text format     Abstract available
    
    
    
21. GREY C, Jackson R, Wells S, Wu B, et al
    First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.
    Heart. 2018;104:51-57.
    PubMed     Text format     Abstract available
    
    
    December 2017
22. STEWART RAH, Colquhoun DM, Marschner SL, Kirby AC, et al
    Persistent psychological distress and mortality in patients with stable coronary artery disease.
    Heart. 2017;103:1860-1866.
    PubMed     Text format     Abstract available
    
    
    
23. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Text format     Abstract available
    
    
    
24. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Text format     Abstract available
    
    
    
25. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.
    PubMed     Text format    
    
    
    
26. SAINSBURY PA, Fisher M, de Silva R
    Alternative interventions for refractory angina.
    Heart. 2017;103:1911-1922.
    PubMed     Text format    
    
    
    November 2017
27. DURKO AP, Budde RPJ, Geleijnse ML, Kappetein AP, et al
    Recognition, assessment and management of the mechanical complications of acute myocardial infarction.
    Heart. 2017 Nov 16. pii: heartjnl-2017-311473. doi: 10.1136/heartjnl-2017-311473
    PubMed     Text format    
    
    
    
28. MANGION K, Gao H, Husmeier D, Luo X, et al
    Advances in computational modelling for personalised medicine after myocardial infarction.
    Heart. 2017 Nov 10. pii: heartjnl-2017-311449. doi: 10.1136/heartjnl-2017-311449
    PubMed     Text format     Abstract available
    
    
    
29. BAI L, Li Q, Wang J, Lavigne E, et al
    Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario.
    Heart. 2017 Nov 3. pii: heartjnl-2017-311821. doi: 10.1136/heartjnl-2017-311821.
    PubMed     Text format     Abstract available
    
    
    
30. MATULEVICIENE-ANANGEN V, Rosengren A, Svensson AM, Pivodic A, et al
    Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
    Heart. 2017;103:1687-1695.
    PubMed     Text format     Abstract available
    
    
    
31. HOORWEG BB, Willemsen RT, Cleef LE, Boogaerts T, et al
    Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses.
    Heart. 2017;103:1727-1732.
    PubMed     Text format     Abstract available
    
    
    
32. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Text format     Abstract available
    
    
    
33. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    PubMed     Text format     Abstract available
    
    
    
34. DENBY KJ, Clark DE, Markham LW
    Management of Kawasaki disease in adults.
    Heart. 2017;103:1760-1769.
    PubMed     Text format     Abstract available
    
    
    
35. HERRINGTON WG, Bragg F
    Extreme ischaemic heart disease risk in people with type 1 diabetes.
    Heart. 2017;103:1656-1657.
    PubMed     Text format    
    
    
    
36. RAHIMI K, Otto CM
    Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
    Heart. 2017;103:1653-1655.
    PubMed     Text format    
    
    
    October 2017
37. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880
    PubMed     Text format    
    
    
    
38. OTTO CM
    Heartbeat: Virtual histopathology after myocardial infarction.
    Heart. 2017;103:1473-1474.
    PubMed     Text format    
    
    
    
39. OTTO CM
    Heartbeat: Ischemic heart disease risk factors in women.
    Heart. 2017;103:1559-1561.
    PubMed     Text format    
    
    
    
40. ASHER E, Kogan A, Segev A
    Severe upper abdominal pain in a 43-year-old woman.
    Heart. 2017;103:1650.
    PubMed     Text format     Abstract available
    
    
    
41. MADONIS SM, Skelding KA, Roberts M
    Management of acute coronary syndromes: special considerations in women.
    Heart. 2017;103:1638-1646.
    PubMed     Text format    
    
    
    September 2017
42. ZHAO M, Vaartjes I, Graham I, Grobbee D, et al
    Sex differences in risk factor management of coronary heart disease across three regions.
    Heart. 2017 Sep 20. pii: heartjnl-2017-311429. doi: 10.1136/heartjnl-2017-311429
    PubMed     Text format     Abstract available
    
    
    
43. ALBADRI A, Wei J, Mehta PK, Shah R, et al
    Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!
    Heart. 2017 Sep 20. pii: heartjnl-2017-311921. doi: 10.1136/heartjnl-2017-311921
    PubMed     Text format    
    
    
    
44. BUTTAR SN, Yan TD, Taggart DP, Tian DH, et al
    Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis.
    Heart. 2017;103:1419-1426.
    PubMed     Text format     Abstract available
    
    
    
45. NAIROOZ R, Saad M, Elgendy IY, Mahmoud AN, et al
    Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials.
    Heart. 2017;103:1427-1434.
    PubMed     Text format     Abstract available
    
    
    
46. WANG M, Vaez M, Dorner TE, Tiihonen J, et al
    Trajectories and characteristics of work disability before and after acute myocardial infarction.
    Heart. 2017 Sep 1. pii: heartjnl-2017-311950. doi: 10.1136/heartjnl-2017-311950.
    PubMed     Text format     Abstract available
    
    
    August 2017
47. BERG J, Bjorck L, Nielsen S, Lappas G, et al
    Sex differences in survival after myocardial infarction in Sweden, 1987-2010.
    Heart. 2017 Aug 7. pii: heartjnl-2016-310281. doi: 10.1136/heartjnl-2016-310281.
    PubMed     Text format     Abstract available
    
    
    
48. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311695. doi: 10.1136/heartjnl-2017-311695.
    PubMed     Text format    
    
    
    
49. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    PubMed     Text format     Abstract available
    
    
    
50. WILSON S, Newby DE
    Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?
    Heart. 2017;103:1143-1145.
    PubMed     Text format    
    
    
    July 2017
51. YILMAZ A
    Visualising inflammation after myocardial infarction with the use of iron oxide nanoparticles.
    Heart. 2017 Jul 20. pii: heartjnl-2017-311484. doi: 10.1136/heartjnl-2017-311484
    PubMed     Text format    
    
    
    
52. FABRIS E, Kilic S, Schellings DAAM, Ten Berg JM, et al
    Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction.
    Heart. 2017 Jul 5. pii: heartjnl-2017-311181. doi: 10.1136/heartjnl-2017-311181.
    PubMed     Text format     Abstract available
    
    
    
53. TIMMIS A, Roobottom CA
    National Institute for Health and Care Excellence updates the stable chest pain guideline with radical changes to the diagnostic paradigm.
    Heart. 2017;103:982-986.
    PubMed     Text format     Abstract available
    
    
    
54. GONZALEZ LOPEZ-VALCARCEL B, Librero J, Garcia-Sempere A, Pena LM, et al
    Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.
    Heart. 2017;103:1082-1088.
    PubMed     Text format     Abstract available
    
    
    
55. ZHOU RH, Yu H, Yin XR, Li Q, et al
    Effect of intralipid postconditioning on myocardial injury in patients undergoing valve replacement surgery: a randomised controlled trial.
    Heart. 2017;103:1122-1127.
    PubMed     Text format     Abstract available
    
    
    
56. SHIMADA YJ, Tsugawa Y, Iso H, Brown DF, et al
    Association between bariatric surgery and rate of hospitalisations for stable angina pectoris in obese adults.
    Heart. 2017;103:1009-1014.
    PubMed     Text format     Abstract available
    
    
    
57. HELSEN F, Vandenberk B, De Meester P, Van De Bruaene A, et al
    Appearance of QRS fragmentation late after Mustard/Senning repair is associated with adverse outcome.
    Heart. 2017;103:1036-1042.
    PubMed     Text format     Abstract available
    
    
    
58. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    PubMed     Text format     Abstract available
    
    
    
59. OHYA M, Kubo S, Kuwayama A, Miura K, et al
    Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.
    Heart. 2017;103:1002-1008.
    PubMed     Text format     Abstract available
    
    
    
60. TIMMIS A, Roobottom C
    Re: The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patients.
    Heart. 2017;103:1055.
    PubMed     Text format    
    
    
    
61. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.
    PubMed     Text format    
    
    
    
62. OTTO CM, Luiz Ribeiro A
    Heartbeat: Anatomy versus physiology for diagnosis of coronary artery disease.
    Heart. 2017;103:969-971.
    PubMed     Text format    
    
    
    June 2017
63. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
    Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
    Heart. 2017 Jun 29. pii: heartjnl-2017-311431. doi: 10.1136/heartjnl-2017-311431
    PubMed     Text format     Abstract available
    
    
    
64. NDREPEPA G
    Psychological distress and mortality in stable coronary heart disease: persistence of high distress means increased risk.
    Heart. 2017 Jun 26. pii: heartjnl-2017-311610. doi: 10.1136/heartjnl-2017-311610
    PubMed     Text format    
    
    
    
65. STIRRAT CG, Alam SR, MacGillivray TJ, Gray CD, et al
    Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction.
    Heart. 2017 Jun 22. pii: heartjnl-2016-311018. doi: 10.1136/heartjnl-2016-311018
    PubMed     Text format     Abstract available
    
    
    
66. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    PubMed     Text format    
    
    
    
67. BIELINSKI SJ, Berardi C, Decker PA, Larson NB, et al
    Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310450. doi: 10.1136/heartjnl-2016-310450.
    PubMed     Text format     Abstract available
    
    
    
68. MOSS AJ, Lim KH, Japp AG
    A 49-year-old with chest pain and collapse.
    Heart. 2017;103:968.
    PubMed     Text format    
    
    
    May 2017
69. RAJANI R, Modi B, Ntalas I, Curzen N, et al
    Non-invasive Fractional Flow Reserve using Computed Tomographic angiography: where are we now and where are we going?
    Heart. 2017 May 30. pii: heartjnl-2016-311029. doi: 10.1136/heartjnl-2016-311029
    PubMed     Text format    
    
    
    
70. LUIZ RIBEIRO A, Satoshi N, Catherine MO
    Heartbeat: Coronary heart disease, obesity, smoking and long-lasting psychological distress.
    Heart. 2017;103:644.
    PubMed     Text format    
    
    
    
71. LI X, Yu C, Guo Y, Bian Z, et al
    Tea consumption and risk of ischaemic heart disease.
    Heart. 2017;103:783-789.
    PubMed     Text format     Abstract available
    
    
    
72. PERERA D, Uppal R, Hogan J
    A 72-year-old male with recurrent syncope.
    Heart. 2017;103:800.
    PubMed     Text format     Abstract available
    
    
    April 2017
73. PRIOR DL, Stevens SR, Holly TA, Krejca M, et al
    Regional left ventricular function does not predict survival in ischaemic cardiomyopathy after cardiac surgery.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310693. doi: 10.1136/heartjnl-2016-310693
    PubMed     Text format     Abstract available
    
    
    
74. CADEMARTIRI F, Nistri S, Tarantini G, Maffei E, et al
    Management of coronary artery disease with cardiac CT beyond gatekeeping.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310473. doi: 10.1136/heartjnl-2016-310473
    PubMed     Text format    
    
    
    
75. HOLTE E, Kleveland O, Ueland T, Kunszt G, et al
    Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
    Heart. 2017 Apr 21. pii: heartjnl-2016-310875. doi: 10.1136/heartjnl-2016-310875
    PubMed     Text format     Abstract available
    
    
    
76. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    PubMed     Text format    
    
    
    
77. WILSON SJ, Newby DE, Dawson D, Irving J, et al
    Duration of dual antiplatelet therapy in acute coronary syndrome.
    Heart. 2017;103:573-580.
    PubMed     Text format     Abstract available
    
    
    
78. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Text format     Abstract available
    
    
    
79. THOMPSON LE, Daugherty SL
    Gender disparities in cardiovascular disease prevention.
    Heart. 2017;103:479-480.
    PubMed     Text format    
    
    
    
80. DE SILVA K, Myat A, Cotton J, James S, et al
    Bleeding associated with the management of acute coronary syndromes.
    Heart. 2017;103:546-562.
    PubMed     Text format    
    
    
    March 2017
81. SEKIGUCHI H, Shimamoto K, Takano M, Kimura M, et al
    Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women.
    Heart. 2017 Mar 11. pii: heartjnl-2016-310272. doi: 10.1136/heartjnl-2016-310272
    PubMed     Text format     Abstract available
    
    
    
82. ANDERSSON DP, Trolle Lagerros Y, Grotta A, Bellocco R, et al
    Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction.
    Heart. 2017 Mar 9. pii: heartjnl-2016-310746. doi: 10.1136/heartjnl-2016-310746.
    PubMed     Text format     Abstract available
    
    
    
83. KUBLER P, Reczuch K
    Optimal stent treatment of cardiogenic shock complicating acute myocardial infarction: bare-metal or drug-eluting stent?
    Heart. 2017 Mar 3. pii: heartjnl-2016-311146. doi: 10.1136/heartjnl-2016-311146.
    PubMed     Text format    
    
    
    
84. WARD-CAVINESS CK, Xu T, Aspelund T, Thorand B, et al
    Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers.
    Heart. 2017 Mar 2. pii: heartjnl-2016-310789. doi: 10.1136/heartjnl-2016-310789.
    PubMed     Text format     Abstract available
    
    
    
85. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Text format     Abstract available
    
    
    
86. MOSS AJ, Dweck MR, Flapan AD
    A 33-year-old man with atypical chest pain.
    Heart. 2017;103:474.
    PubMed     Text format     Abstract available
    
    
    February 2017
87. WILLIAMS MC, Hunter A, Shah A, Assi V, et al
    Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial.
    Heart. 2017 Feb 28. pii: heartjnl-2016-310129. doi: 10.1136/heartjnl-2016-310129
    PubMed     Text format     Abstract available
    
    
    
88. LEDWOCH J, Fuernau G, Desch S, Eitel I, et al
    Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock.
    Heart. 2017 Feb 7. pii: heartjnl-2016-310403. doi: 10.1136/heartjnl-2016-310403.
    PubMed     Text format     Abstract available
    
    
    January 2017
89. DANZI GB, Piccolo R, Chevalier B, Urban P, et al
    Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.
    Heart. 2017;103:111-116.
    PubMed     Text format     Abstract available
    
    
    
90. BUENO H, Pocock S, Danchin N, Annemans L, et al
    International patterns of dual antiplatelet therapy duration after acute coronary syndromes.
    Heart. 2017;103:132-138.
    PubMed     Text format     Abstract available
    
    
    
91. VARCOE RW, Clayton TC, Gray HH, de Belder MA, et al
    Impact of call-to-balloon time on 30-day mortality in contemporary practice.
    Heart. 2017;103:117-124.
    PubMed     Text format     Abstract available
    
    
    
92. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.
    PubMed     Text format    
    
    
    
93. GIAVARINI A, Kilic ID, Redondo Dieguez A, Longo G, et al
    Intracoronary Imaging.
    Heart. 2017 Jan 5. pii: heartjnl-2015-307888. doi: 10.1136/heartjnl-2015-307888.
    PubMed     Text format    
    
    
    
94. CHAPMAN AR, Adamson PD, Mills NL
    Assessment and classification of patients with myocardial injury and infarction in clinical practice.
    Heart. 2017;103:10-18.
    PubMed     Text format     Abstract available
    
    
    December 2016
95. WILLIAMS RB
    Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications.
    Heart. 2016;102:2016.
    PubMed     Text format    
    
    
    
96. REINDL M, Reinstadler SJ, Feistritzer HJ, Mueller L, et al
    Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction.
    Heart. 2016 Dec 15. pii: heartjnl-2016-310520. doi: 10.1136/heartjnl-2016-310520
    PubMed     Text format     Abstract available
    
    
    
97. DOMINGUEZ-RODRIGUEZ A, Abreu-Gonzalez P, Reiter RJ
    Melatonin for cardioprotection in ST elevation myocardial infarction: are we ready for the challenge?
    Heart. 2016 Dec 7. pii: heartjnl-2016-310689. doi: 10.1136/heartjnl-2016-310689.
    PubMed     Text format    
    
    
    
98. JENKINS WS, Vesey AT, Stirrat C, Connell M, et al
    Cardiac alphaVbeta3 integrin expression following acute myocardial infarction in humans.
    Heart. 2016 Dec 7. pii: heartjnl-2016-310115. doi: 10.1136/heartjnl-2016-310115.
    PubMed     Text format     Abstract available
    
    
    November 2016
99. LLOYD A, Steele L, Fotheringham J, Iqbal J, et al
    Pronounced increase in risk of acute ST-segment elevation myocardial infarction in younger smokers.
    Heart. 2016 Nov 29. pii: heartjnl-2016-309595. doi: 10.1136/heartjnl-2016-309595
    PubMed     Text format     Abstract available
    
    
    
100. EISEN A, Bhatt DL
     Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
     Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022
     PubMed     Text format    
     
     
     
101. VIRTANEN M, Elovainio M, Josefsson K, Batty GD, et al
     Coronary heart disease and risk factors as predictors of trajectories of psychological distress from midlife to old age.
     Heart. 2016 Nov 18. pii: heartjnl-2016-310207. doi: 10.1136/heartjnl-2016-310207
     PubMed     Text format     Abstract available
     
     
     
102. MCMULLAN CJ, Rimm EB, Schernhammer ES, Forman JP, et al
     A nested case-control study of the association between melatonin secretion and incident myocardial infarction.
     Heart. 2016 Nov 2. pii: heartjnl-2016-310098. doi: 10.1136/heartjnl-2016-310098.
     PubMed     Text format     Abstract available
     
     
     
103. CHAPMAN AR, Anand A, Shah AS, Adamson PD, et al
     Response: a novel troponin I rule-out value below the upper reference limit for acute myocardial infarction.
     Heart. 2016;102:1772.
     PubMed     Text format    
     
     
     October 2016
104. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
     Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
     Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
     PubMed     Text format     Abstract available
     
     
     September 2016
105. GURUNATHAN S, Ahmed A, Pabla J, Karogiannis N, et al
     The clinical efficacy and long-term prognostic value of stress echocardiography in octogenarians.
     Heart. 2016 Sep 30. pii: heartjnl-2016-310026. doi: 10.1136/heartjnl-2016-310026
     PubMed     Text format     Abstract available
     
     
     
106. MACINTYRE CR, Mahimbo A, Moa AM, Barnes M, et al
     Influenza vaccine as a coronary intervention for prevention of myocardial infarction.
     Heart. 2016 Sep 29. pii: heartjnl-2016-309983. doi: 10.1136/heartjnl-2016-309983
     PubMed     Text format     Abstract available
     
     
     
107. NAIR A, Sajeev CG, Muneer K
     A case of recent myocardial infarction with cardiac failure.
     Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
     PubMed     Text format     Abstract available
     
     
     
108. JONES DA, Khambata RS, Andiapen M, Rathod KS, et al
     Intracoronary nitrite suppresses the inflammatory response following primary percutaneous coronary intervention.
     Heart. 2016 Sep 28. pii: heartjnl-2016-309748. doi: 10.1136/heartjnl-2016-309748
     PubMed     Text format     Abstract available
     
     
     
109. OU SM, Chen HT, Kuo SC, Chen TJ, et al
     Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
     Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
     PubMed     Text format     Abstract available
     
     
     
110. COCKBURN J, Hildick-Smith D, Trivedi U, de Belder A, et al
     Coronary revascularisation in the elderly.
     Heart. 2016 Sep 14. pii: heartjnl-2015-308999. doi: 10.1136/heartjnl-2015-308999
     PubMed     Text format    
     
     
     August 2016
111. SHAH R, Mooney MA
     Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
     Heart. 2016;102:1335.
     PubMed     Text format    
     
     
     
112. NAVARESE E, Kowalewski M
     Complete versus culprit-only revascularisation for ST-segment elevation myocardial infarction.
     Heart. 2016;102:1335-6.
     PubMed     Text format    
     
     
     
113. BRADLEY SM, Otto CM
     Heartbeat: Rule-out of acute myocardial infarction - risky business.
     Heart. 2016;102:1249-50.
     PubMed     Text format    
     
     
     
114. MANGION K, Carrick D, Hennigan BW, Payne AR, et al
     Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.
     Heart. 2016 Aug 8. pii: heartjnl-2015-308660. doi: 10.1136/heartjnl-2015-308660.
     PubMed     Text format     Abstract available
     
     
     
115. LINDAHL B, Jernberg T, Badertscher P, Boeddinghaus J, et al
     An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay.
     Heart. 2016 Aug 2. pii: heartjnl-2016-309951. doi: 10.1136/heartjnl-2016-309951.
     PubMed     Text format     Abstract available
     
     
     
116. OTTO CM
     Heartbeat: Prediction of coronary disease risk with cardiac troponin in the general population.
     Heart. 2016;102:1151-2.
     PubMed     Text format    
     
     
     July 2016
117. DI TANO G, Caretta G, De Maria R, Parolini M, et al
     Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
     Heart. 2016 Jul 27. pii: heartjnl-2016-309673. doi: 10.1136/heartjnl-2016-309673
     PubMed     Text format     Abstract available
     
     
     
118. DEVI R, Singh SJ, Powell J, Fulton EA, et al
     Cochrane Corner: are there benefits of using web-based interventions in the secondary prevention of coronary heart disease?
     Heart. 2016 Jul 21. pii: heartjnl-2015-309138. doi: 10.1136/heartjnl-2015-309138
     PubMed     Text format    
     
     
     
119. PETRONI T, Zaman A, Georges JL, Hammoudi N, et al
     Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians.
     Heart. 2016 Jul 13. pii: heartjnl-2015-308905. doi: 10.1136/heartjnl-2015-308905
     PubMed     Text format     Abstract available
     
     
     
120. MITTAL TK, Reichmuth L, Ariff B, Rao PP, et al
     Imaging diagnoses and outcome in patients presenting for primary angioplasty but no obstructive coronary artery disease.
     Heart. 2016 Jul 1. pii: heartjnl-2015-309039. doi: 10.1136/heartjnl-2015-309039.
     PubMed     Text format     Abstract available
     
     
     June 2016
121. PARSONAGE WA, Mueller C, Greenslade JH, Wildi K, et al
     Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests.
     Heart. 2016 Jun 10. pii: heartjnl-2016-309270. doi: 10.1136/heartjnl-2016-309270
     PubMed     Text format     Abstract available
     
     
     May 2016
122. PUDDU PE, Alexandre J
     Coronary heart disease and sexual activity.
     Heart. 2016 May 12. pii: heartjnl-2016-309505. doi: 10.1136/heartjnl-2016-309505
     PubMed     Text format    
     
     
     
123. NORDMANN A, Schwartz G, Vale N, Bucher HC, et al
     Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
     Heart. 2016;102:653-4.
     PubMed     Text format    
     
     
     April 2016
124. HEMKENS LG, Ewald H, Gloy VL, Arpagaus A, et al
     Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
     Heart. 2016;102:590-6.
     PubMed     Text format     Abstract available
     
     
     
125. SHAVELLE DM
     Almanac 2015: coronary artery disease.
     Heart. 2016;102:492-9.
     PubMed     Text format     Abstract available
     
     
     March 2016
126. BRICENO N, Schuster A, Lumley M, Perera D, et al
     Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.
     Heart. 2016;102:397-406.
     PubMed     Text format    
     
     
     
127. BULLUCK H, Yellon DM, Hausenloy DJ
     Reducing myocardial infarct size: challenges and future opportunities.
     Heart. 2016;102:341-8.
     PubMed     Text format     Abstract available
     
     
     
128. GAIBAZZI N
     Ultrasound contrast during stress echo: for obese patients, but not only.
     Heart. 2016;102:339-40.
     PubMed     Text format    
     
     
     
129. TARKIA M, Stark C, Haavisto M, Kentala R, et al
     Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
     Heart. 2016;102:465-71.
     PubMed     Text format     Abstract available
     
     
     
130. BUDOFF MJ
     Exercise capacity and biological age.
     Heart. 2016;102:415.
     PubMed     Text format    
     
     
     
131. BLAHA MJ, Hung RK, Dardari Z, Feldman DI, et al
     Age-dependent prognostic value of exercise capacity and derivation of fitness-associated biologic age.
     Heart. 2016;102:431-7.
     PubMed     Text format     Abstract available
     
     
     
132. ARRI SS, Ryan M, Redwood SR, Marber MS, et al
     Mental stress-induced myocardial ischaemia.
     Heart. 2016;102:472-80.
     PubMed     Text format    
     
     
     
133. MISTRY A, McCann G, Skehan D
     Ischaemic chest pain in a 65-year-old man.
     Heart. 2016;102:471.
     PubMed     Text format    
     
     
     February 2016
134. VELDERS MA, Abtan J, Angiolillo DJ, Ardissino D, et al
     Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
     Heart. 2016 Feb 4. pii: heartjnl-2015-308963. doi: 10.1136/heartjnl-2015-308963.
     PubMed     Text format     Abstract available
     
     
     January 2016
135. FORDYCE CB, Douglas PS
     Optimal non-invasive imaging test selection for the diagnosis of ischaemic heart disease.
     Heart. 2016 Jan 29. pii: heartjnl-2015-307764. doi: 10.1136/heartjnl-2015-307764
     PubMed     Text format    
     
     
     
136. AGUS AM, McKavanagh P, Lusk L, Verghis RM, et al
     The cost-effectiveness of cardiac computed tomography for patients with stable chest pain.
     Heart. 2016 Jan 14. pii: heartjnl-2015-308247. doi: 10.1136/heartjnl-2015-308247
     PubMed     Text format     Abstract available
     
     
     
137. SHAH BN, Zacharias K, Pabla JS, Karogiannis N, et al
     The clinical impact of contemporary stress echocardiography in morbid obesity for the assessment of coronary artery disease.
     Heart. 2016 Jan 6. pii: heartjnl-2015-308796. doi: 10.1136/heartjnl-2015-308796.
     PubMed     Text format     Abstract available
     
     
     
138. SINCLAIR H, Kunadian V
     Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes.
     Heart. 2016 Jan 6. pii: heartjnl-2015-307859. doi: 10.1136/heartjnl-2015-307859.
     PubMed     Text format     Abstract available
     
     
     
139. CULLEN L, Greenslade JH, Carlton EW, Than M, et al
     Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain.
     Heart. 2016;102:120-6.
     PubMed     Text format     Abstract available
     
     
     
140. GIANNITSIS E
     Sex-specific troponin measures for diagnosis of acute coronary syndrome.
     Heart. 2016;102:91-2.
     PubMed     Text format    
     
     
     
141. TASEVSKA I, Enhorning S, Persson M, Nilsson PM, et al
     Copeptin predicts coronary artery disease cardiovascular and total mortality.
     Heart. 2016;102:127-32.
     PubMed     Text format     Abstract available
     
     
     December 2015
142. DASTIDAR AG, Rodrigues JC, Baritussio A, Bucciarelli-Ducci C, et al
     MRI in the assessment of ischaemic heart disease.
     Heart. 2015 Dec 30. pii: heartjnl-2014-306963. doi: 10.1136/heartjnl-2014-306963
     PubMed     Text format    
     
     
     
143. SINTEK MA, Sparrow CT, Mikuls TR, Lindley KJ, et al
     Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis.
     Heart. 2015 Dec 30. pii: heartjnl-2015-308634. doi: 10.1136/heartjnl-2015-308634
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: